Ticker Short Interest

MESO Short Interest Intelligence

Mesoblast Ltd positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

MESO is classified as Neutral. Latest reported short interest is 3.1M shares; short interest changed -0.2%, price moved -5.3% since the previous report, short interest is in the 71th percentile, and days to cover is in the 43th percentile. Trend context is weak.

Setup Score59/100Neutral
Reported Short Interest3.1M-0.2% vs prior report
Days To Cover14.8542.86 percentile
Price Reaction-5.3%since previous short report
Squeeze Pressure29crowding, trend, and pressure
Bearish Conviction45shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

29

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

45

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

59

Latest short interest is 3.1M shares and days to cover is 14.85.

Divergence

27

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

MESO Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 3103325 3108248 -0.2% 14.85 209001
15 Jun 2026 3108248 3061116 1.5% 21.02 147876
29 May 2026 3061116 2941703 4.1% 17.23 177675
15 May 2026 2941703 2905555 1.2% 17.91 164276
30 Apr 2026 2905555 3049603 -4.7% 17.46 166389
15 Apr 2026 3049603 3162637 -3.6% 10.68 285476
31 Mar 2026 3162637 3210810 -1.5% 10.83 291994

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.